SPHK
Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
CSN20618 | SKI-178 | 1259484-97-3 | SKI-178 is an in vivo active non-lipid sphingosine kinase 1 SphK1 inhibitor IC50 01-18 M which induces CDK1-dependent apoptosis in human acute myeloid leukemia cell lines |
CSN18688 | SKI II | 312636-16-1 | SKI II is an inhibitor of non ATP-competitive sphingosine kinase SphK with IC50 of 05 M |
CSN17817 | PF-543 | 1415562-82-1 | PF-543 is a cell-permeant inhibitor of SphK1 with a Ki of 36 nM PF-543 is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform |
CSN23038 | PF-543 hydrochloride | 1706522-79-3 | PF-543 HCl is a cell-permeant inhibitor of SphK1 with a Ki of 36 nM PF-543 is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform |
CSN17818 | PF-543 Citrate | 1415562-83-2 | PF-543 citrate is a cell-permeant inhibitor of SphK1 with a K i of 36 nM PF-543 is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform |
CSN18116 | MP-A08 | 219832-49-2 | MP-A08 is a highly selective ATP competitive SK inhibitor that targets both SK1 and SK2 with Kivalues of 69 08 M and 27 3 M respectively |
CSN17675 | K145 | 1309444-75-4 | K145 is a selective SphK2 inhibitor with an IC50 of 430006 M while no inhibition of SphK1 at concentrations up to 10 M |
CSN17876 | K145 hydrochloride | 1449240-68-9 | K145 HCl is a selective SphK2 inhibitor with an IC50 of 4.30±0.06 μM , while no inhibition of SphK1 at concentrations up to 10 μM. |
CSN24154 | MHP | 1104874-94-3 | Defensamide is an activator of SPHK1, and significantly stimulates CAMP mRNA and protein production in KC. |
CSN16869 | Opaganib | 915385-81-8 | ABC294640 markedly alters the ratio of ceramide/S1P consistent with inhibition of SK activity in MDA-MB-231 cells. |